Back to news
PEPTOMYC, the spin off led by Laura Soucek (ICREA at VHIO) has just raised 1 million to complete preclinical developent of a novel tumor inhibitor, a peptyde that blocks the MYC gene, which sits in the centrer of all the signalling cascade that leads to tumor groth and proliferation. Blocking MYC has proved very successful in preclical trials: tumors seem unable to find a way around MYC, and recede very dramatically.
We wish them best of luck and we hope to see the therapy in use some time, sooner rather than later!
OTHER NEWS
The ICREA researcher David R. M. Irving is awarded the prestigious Dent Medal 2026.
The Royal Musical Association has awarded David R. M. Irving, an ICREA Research Professor at the CSIC’s Milà i Fontanals…
Investiture ceremony of Helga Nowotny and Maria Leptin as honorary doctors from the UPF
Jan Eeckhout and Carla Lancelotti, ICREA Research Professors at the UPF Departments of Economics and Business and Humanities, will give…
